The growth hormone (GH)–insulin-like growth factor 1 (IGF1) axis regulates bone remodelling and metabolism. This Review highlights the pathophysiological and clinical aspects of skeletal fragility associated with perturbations in the GH–IGF1 axis such as GH deficiency, anorexia nervosa, ageing and acromegaly.
- Gherardo Mazziotti
- Andrea G. Lania
- Ernesto Canalis